Uterine Sarcoma
📧 Sign up to get email alerts when something new happens for Uterine Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer [Phase 2]
Phase 2 clinical trial evaluating imatinib mesylate in patients with recurrent or persistent uterine cancer has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating Ziv-aflibercept in locally advanced, unresectable, or metastatic gynecologic soft tissue sarcoma has completed with…
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Sorafenib in Treating Patients With Advanced or Recurrent Uterine Cancer [Phase 2]
Phase 2 trial of sorafenib in advanced or recurrent uterine cancer has completed and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-01-30Clinical Trial Update: Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery [Phase 2]
Phase 2 trial results for Therapeutic Angiotensin-(1-7) in patients with unresectable metastatic sarcoma have results posted.
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma [Phase 2]
Phase 2 clinical trial evaluating sorafenib for metastatic, locally advanced, or recurrent sarcoma has completed and posted results in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies [Phase 2]
This report covers results from a Phase 2 trial using the CyberKnife stereotactic radiosurgery system to treat advanced or recurrent gynecol…
-
CLINICAL_TRIALS trial_result · 2013-07-09Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus [Phase 2]
Phase 2 trial evaluating combination chemotherapy for recurrent or advanced uterine cancer (uterine sarcoma). The study has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-06-10Clinical Trial Update: Chemotherapy in Treating Patients With Sarcoma of the Uterus [Phase 2]
Phase 2 chemotherapy trial for sarcoma of the uterus has been completed, involving patients with endometrial cancer and uterine sarcoma.
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus [Phase 2]
This update reports the termination of a Phase 2 trial of topotecan in patients with recurrent or refractory uterine cancer (uterine sarcoma…
-
CLINICAL_TRIALS trial_result · 2013-04-11Clinical Trial Update: Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus [Phase 2]
A Phase 2 trial of gemcitabine for recurrent or refractory uterine cancer (uterine sarcoma) was terminated.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors [NA]
A completed clinical trial evaluated pelvic floor muscle training for urinary incontinence in survivors of gynecologic cancers.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Radiation Therapy or No Further Treatment Following Surgery in Treating Patients With Cancer of the Uterus [Phase 3]
A Phase 3 trial comparing adjuvant radiation therapy versus no further treatment after surgery for uterine cancer has completed.
-
CLINICAL_TRIALS research · 2007-08-10Clinical Trial Update: The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas [Phase 3]
Phase 3 clinical trial evaluating whether adding polychemotherapy to adjuvant radiotherapy improves outcomes in non-metastatic uterine sarco…